22nd Annual Multidisciplinary Symposium on Breast Disease is organized by Florida Society of Clinical Oncology (FLASCO) and would be held during Feb 9 - 12, 2017 at The Ritz-Carlton, Amelia Island, Fernandina Beach, Florida, United States of America.
The target audience for this medical event are Oncologists. This CME conference has been approved with a maximum of 24.75 AMA PRA Category 1 Credits.
Objectives
Upon completion of this course, participants should be able to:
• Review controversies regarding under and over diagnosis
• Review controversies surrounding breast cancer screening
• Identify molecular markers as prognostic and predictive tools
• Outline strategies for preservation of fertility and pregnancy in young women post-treatment
• Assess the contribution of multi-modality breast cancer screening and imaging techniques and technologies, including traditional and contemporary breast imaging.
• Discuss the complications of breast cancer in elderly patients
• Describe risk assessment tools to identify high-risk patients
• Recognize the challenges and advantages of nipple-sparing mastectomy
• Review concepts in evaluating genomic assays as risk predictors
• Discuss the current status of intraoperative radiation therapy
• Review the issues surrounding chemoprevention and risk reduction modalities
• Discuss the post breast cancer symptom management